Relevant bibliographies by topics / Giacomo Bettoli

Contents

  1. Journal articles
  2. Dissertations / Theses

Academic literature on the topic 'Giacomo Bettoli'

Author: Grafiati
Published: 9 March 2023
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Giacomo Bettoli.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Giacomo Bettoli"

1

RGI, Redazione. "Informazione bibliografica." RIVISTA GEOGRAFICA ITALIANA, no. 2 (June 2021): 155–86. http://dx.doi.org/10.3280/rgioa2-2021oa12038.

Full text
Abstract:
L'Informazione bibliografica del numero 2/2021 della «Rivista Geografica Italiana» presenta le recensioni dei seguenti testi. Rachele Borghi, Decolonialità e privilegio. Pratiche femministe e critica al sistema-mondo (Marcella Schmidt di Friedberg) Mauro Varotto, Montagne di mezzo. Una nuova geografia (Giacomo Pettenati)  Alberto Magnaghi, Il principio territoriale (Giuseppe Dematteis) Domenico Cersosimo, Carmine Donzelli, a cura di, Manifesto per riabitare l'Italia (Matteo Puttilli) Luca Gaeta, Alice Buoli, a cura di, Transdisciplinary Views on Boundari
APA, Harvard, Vancouver, ISO, and other styles
2

Bettiol, A., M. L. Urban, F. Alberici, et al. "OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 94–95. http://dx.doi.org/10.1136/annrheumdis-2020-eular.5544.

Full text
Abstract:
Background:Evidence on the efficacy of Mepolizumab (MEPO) in Eosinophilic Granulomatosis with Polyangiitis (EGPA) is scarce [1].Objectives:To assess the efficacy and safety of MEPO in real-life clinical practice.Methods:We retrospectively included patients diagnosed with EGPA and treated with MEPO (100 or 300 mg/month). MEPO efficacy was evaluated in the first 12 months in terms of systemic disease and asthma control. The occurrence of any adverse event (AE) was recorded.Results:142 patients were included (38% males; median age 46.4 (IQR 36.7-54.4); 110 and 32 on MEPO 100 and 300 mg/month, res
APA, Harvard, Vancouver, ISO, and other styles
3

Bettiol, A., I. Mattioli, M. L. Urban, et al. "OP0304 BENRALIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): RESULTS FROM A EUROPEAN MULTICENTER STUDY ON 121 PATIENTS." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 196.1–197. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1510.

Full text
Abstract:
BackgroundEosinophilic granulomatosis with polyangiitis (EGPA) is an ANCA-associated vasculitis characterized by asthma, ear-nose-throat (ENT) manifestations, peripheral hypereosinophilia and systemic vasculitic involvement [1]. Increased serum levels of interleukin 5 (IL-5) have been observed in eosinophilic disorders, including EGPA, and a genome-wide association study identified the IL-5 region as a major EGPA-associated loci [2]. On these bases, an increasing interest is focusing on benralizumab (an IL-5 receptor antagonist approved for severe eosinophilic asthma at the dosage of 30mg ever
APA, Harvard, Vancouver, ISO, and other styles
4

Santaniello, A., C. Bellocchi, L. Bettolini, et al. "OP0009 DERIVATION AND VALIDATION OF THE SCLERODERMA LUNG 3-STAGE INDEX (SL3SI), A NEW FUNCTIONAL INDEX FOR INTERSTITIAL LUNG DISEASE WITH PROGNOSTIC IMPLICATIONS." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 7.2–7. http://dx.doi.org/10.1136/annrheumdis-2020-eular.5788.

Full text
Abstract:
Background:The staging of interstitial lung disease (ILD) is important to monitor disease progression and for prognostication. A disease severity scale of Systemic Sclerosis (SSc)-related lung disease has long been proposed (i.e. Medsger’s severity scale). This scale was mostly developed by discussion and consensus and stage thresholds were not computed by a data-driven approach. Hidden Markov models (HMM) are methods to estimate population quantities for chronic diseases with a staged interpretation which are diagnosed by markers measured at irregular intervals.Objectives:To build a SSc-ILD s
APA, Harvard, Vancouver, ISO, and other styles
5

Bettiol, A., M. L. Urban, F. Bello, et al. "POS0246 SEQUENTIAL RITUXIMAB AND MEPOLIZUMAB IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 362.2–363. http://dx.doi.org/10.1136/annrheumdis-2022-eular.4320.

Full text
Abstract:
BackgroundRituximab (RTX) is an effective remission-induction treatment in ANCA-associated vasculitides (AAVs). Some reports have suggested that it might be effective also in Eosinophilic Granulomatosis with Polyangiitis (EGPA), to induce and maintain remission of vasculitic manifestations [1,2]. However, its effects for preventing respiratory relapses seem to be poor. Mepolizumab (Mepo) (both 100 and 300mg/month) is effective in improving respiratory manifestations and lung function, while partially controlling also systemic activity [3,4]. Isolated case reports further indicate that the sequ
APA, Harvard, Vancouver, ISO, and other styles
6

Berti, A., M. Ottone, S. Sartorelli, et al. "POS1176 HOSPITALIZATION RATES, FEATURES, AND DISCHARGE DIAGNOSES OF A LARGE NATIONWIDE COHORT OF ANCA-ASSOCIATED VASCULITIS." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 920.2–921. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6039.

Full text
Abstract:
BackgroundHospitalizations due to relapse or disease complications are major concerns during follow-up of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).ObjectivesTo determine rates of hospitalization in a large cohort of patients with AAV compared with the national general population, and to describe features and associated primary discharge diagnoses.MethodsBetween 2007 and 2018, we examined the hospitalization records of AAV patients from 13 Italian hospitals. Hospitalization dates, features, length of stay, primary discharge diagnoses and patient data were abstracte
APA, Harvard, Vancouver, ISO, and other styles
7

Squizzato, Alessandra, and Lorenzo Tunesi. "Foreign travellers in Milan and their interests." Journal of the History of Collections, June 17, 2024. http://dx.doi.org/10.1093/jhc/fhae021.

Full text
Abstract:
Abstract This article reviews the presence and movements of foreign travellers in Milan in the mid-nineteenth century, focusing on the cultural context of art collecting. Perceptions of the Milan region abroad are examined through a number of guides and illustrated digests aimed at foreign visitors and produced by local publishers such as Giovanni Pietro Giegler, Ferdinando Artaria, Bettalli and Vallardi. Along with the main landmarks, the importance of private palaces and their art galleries has also been researched. Among them are locations associated with some established names (the Archint
APA, Harvard, Vancouver, ISO, and other styles
8

Bettiol, A., M. L. Urban, F. Alberici, et al. "OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS." January 25, 2021. https://doi.org/10.1136/annrheumdis-2020-eular.5544.

Full text
Abstract:
Background:Evidence on the efficacy of Mepolizumab (MEPO) in Eosinophilic Granulomatosis with Polyangiitis (EGPA) is scarce [1].Objectives:To assess the efficacy and safety of MEPO in real-life clinical practice.Methods:We retrospectively included patients diagnosed with EGPA and treated with MEPO (100 or 300 mg/month). MEPO efficacy was evaluated in the first 12 months in terms of systemic disease and asthma control. The occurrence of any adverse event (AE) was recorded.Results:142 patients were included (38% males; median age 46.4 (IQR 36.7-54.4); 110 and 32 on MEPO 100 and 300 mg/month, res
APA, Harvard, Vancouver, ISO, and other styles
9

Santaniello, A., C. Bellocchi, L. Bettolini, et al. "OP0009 DERIVATION AND VALIDATION OF THE SCLERODERMA LUNG 3-STAGE INDEX (SL3SI), A NEW FUNCTIONAL INDEX FOR INTERSTITIAL LUNG DISEASE WITH PROGNOSTIC IMPLICATIONS." January 25, 2021. https://doi.org/10.1136/annrheumdis-2020-eular.5788.

Full text
Abstract:
Background:The staging of interstitial lung disease (ILD) is important to monitor disease progression and for prognostication. A disease severity scale of Systemic Sclerosis (SSc)-related lung disease has long been proposed (i.e. Medsger's severity scale). This scale was mostly developed by discussion and consensus and stage thresholds were not computed by a data-driven approach. Hidden Markov models (HMM) are methods to estimate population quantities for chronic diseases with a staged interpretation which are diagnosed by markers measured at irregular intervals.Objectives:To build a SSc-ILD s
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Giacomo Bettoli"

1

CAVENAGO, MARCO. "ARTE SACRA IN ITALIA: LA SCUOLA BEATO ANGELICO DI MILANO (1921-1950)." Doctoral thesis, Università degli Studi di Milano, 2021. http://hdl.handle.net/2434/829725.

Full text
Abstract:
Nell’ottobre del 1921 a Milano nacque la Scuola Superiore di Arte Cristiana Beato Angelico. Responsabili dell’iniziativa: don Giuseppe Polvara, l’architetto Angelo Banfi, il pittore Vanni Rossi, affiancati dallo scultore Franco Lombardi, dai sacerdoti Adriano e Domenico Bernareggi, dall’ingegner Giovanni Dedè, dal professor Giovanni Mamone e dall’avvocato Carlo Antonio Vianello. Gli allievi del primo anno scolastico furono nove, due dei quali (gli architetti don Giacomo Bettoli e Fortunato De Angeli) destinati a restare per lunghi anni nella Scuola come docenti: così avvenne anche col pittore
APA, Harvard, Vancouver, ISO, and other styles
2

Catana, Elio Patrick. "Roles of Betto in Giacomo Puccini's Gianni Schicchi and Aeneas in Henry Purcell's Dido and Aeneas." Thesis, 2002. http://hdl.handle.net/2429/12037.

Full text
Abstract:
This thesis submission includes two very different roles for consideration as my thesis role. They include the role of Betto from Giacomo Puccini's "Gianni Schicchi" an opera based on a portion of Dante's Inferno and Aeneas from Henry Purcell's "Dido and Aeneas" derived from Virgil's The Aeneid. The performances for these one-act operas took place live at The Chan Centre for the Performing Arts between the dates of March 7- 10, 2002. The role of Betto may be considered as the comic role portion of my thesis. In the setting of the opera, he is the poorest of the relations to Buoso Donati
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography